FOR IMMEDIATE RELEASE
WESTBURY, N.Y., October 3, 2017 (Newswire.com) – RXVIP Enterprises, LTD will help create a network of Pharmacists, PharmDs and Students of Pharmacy to educate and raise awareness about a life-saving Pharmacogenetic (PGx) test that can help lower the risk of adverse drug reactions. RXVIP will collaborate with Caregiver Support Services, Omaha Nebraska, an industry leader in providing resources for caregivers nationwide and MedXPrime, a marketing group that delivers medical solutions to physicians.
Ken Newton, COO for MedXPrime, explains: “MedXPrime offers ‘Personalized Medicine’ in the form of PGx testing helping to avoid Adverse Drug Reactions (ADRs) and increase the efficacy of patients’ medications. This valuable service introduces an 8-year-old test that is literally ‘Tomorrow’s Medicine, Today,’ and helps to save lives in the process. Over 125,000 people die each year from ADRs, the 4th leading cause of death in America, a completely needless tragedy.”
Newton continues: “ADRs affect millions of people, with over 2 million people hospitalized each year. Major medical institutions like the Mayo Clinic, St. Jude Children’s Hospital, Stanford, Duke and Vanderbilt University Medical Centers, along with many others, have adopted PGx testing. This is now an ideal time and a perfect intersection for RXVIP Concierge Pharmacists to educate caregivers so they can assist physicians and patients to avoid ADRs with a very simple, life-saving test. Our credo is that “Every Doctor, Every Patient” and now ‘Every Caregiver’ needs to know about these tests as well.”
RXVIP Enterprises has collaborative practice agreements with physicians that allow Pharmacists to meet with patients and provide meaningful consultations at the Point of Care. With a focus on providing care, compassion and empathy to Medicare patients with chronic disease states, this new alliance with Caregiver Support Services, Omaha Nebraska, and MedXPrime will help save lives.
“We believe that in the future, physicians will be unable to prescribe medications without reviewing the genetic profile of the patient. Our company is committed to helping Pharmacists and the next generation of PharmDs get trained and certified through our relationship with MedXPrime, to offer these tests to physicians so that more patients who need them can get them.” said Ken Sternfeld, Founder of RXVIP Enterprises. “The alliance with Caregiving Support Services allows us to extend our educational footprint to help caregivers provide better health solutions for their loved ones.” Sternfeld concluded.
“With RXVIP and MedXPrime collaborating in this marketing effort with us, we are bringing more assistance and resources to our members, by opening up the dialogue that these tests exist and are covered by Medicare so that more patients can be helped,” stated Dr. Eboni Green, Co-Founder of Caregiver Support Services, Omaha Nebraska. With all of us involved in this alliance, caregivers will be educated on how to prevent Adverse Drug Reactions with a very simple test. This strategic marketing initiative will help raise awareness so that more caregivers will know about this life-saving PGx test,” Green concluded.
Caregiver Support Services, Omaha Nebraska will offer a series of online resources for all caregivers interested in bringing this solution to their patients and the physicians who treat them. The first online presentation will coincide with National Caregivers Month in November and carry on into 2018 as an education series, hosted by Caregiver Support Services, MedXprime and RXVIP speakers.
About Pharmacogenomics & Pharmacogenetics
Pharmacogenomics testing reviews individual genetic makeup to identify the likelihood of ADRs, thereby reducing occurrences among the patient population; increasing drug efficacy; increasing adherence through patients’ first-hand positive experiences, encouraging treatment continuity; and reducing healthcare costs incurred from ADRs, poor efficacy and lack of patient adherence.
Pharmacogenetics is the study of how a person’s genetic makeup affects the metabolism of medications. Pharmacogenetic testing (PGx) detects normal and single nucleotide polymorphism (SNPs) in the alleles of genes and their associated enzymes. PGx results, therefore, predict a person’s ability to metabolize certain medications. From a patient effectiveness standpoint, it’s the next major breakthrough in medicine.
Pharmacogenetic testing (PGx) results provide physicians with concise, medically actionable information about a patient’s genotype, thus allowing them to make effective treatment decisions. Because a patient’s genotype remains constant, PGx results can be used to inform medical treatment throughout their lifetime. Utilization of PGx tests by physicians and health care providers will drive the reduction of patient ADRs, while concurrently increasing drug efficacy and patient adherence. As such, adoption of proactive pharmacogenomics testing will lower health care costs and improve patient quality of life.
About Caregiver Support Services
Caregiver Support Services is a “grassroots” non-profit organization with a 501 (c )(3) tax-exempt status. The organization was founded by Terrence and Eboni Green, a husband and wife team, to support family & professional caregivers across the lifespan through direct supportive services. Caregiver Support Services is known nationally for setting up benchmark programs and services for family and professional caregivers in the form of offering accessible training, self-advocacy and other pertinent services to support caregivers through the care process. Visit www.caregiversupportservices.org
Caregiver Support Services
PO Box 4291
Omaha, NE 68104
SOURCE: Press Release by RXVIP